Page last updated: 2024-09-03

garenoxacin and ciprofloxacin

garenoxacin has been researched along with ciprofloxacin in 37 studies

Compound Research Comparison

Studies (garenoxacin)	Trials (garenoxacin)	Recent Studies (post-2010) (garenoxacin)	Studies (ciprofloxacin)	Trials (ciprofloxacin)	Recent Studies (post-2010) (ciprofloxacin)
195	19	46	16,060	1,331	6,092

Protein Interaction Comparison

Protein	Taxonomy	ciprofloxacin (IC50)
Gamma-aminobutyric acid receptor subunit pi	Rattus norvegicus (Norway rat)	0.41
DNA gyrase subunit B	Bacillus subtilis subsp. subtilis str. 168	6.3
DNA gyrase subunit A	Bacillus subtilis subsp. subtilis str. 168	6.3
Cytochrome P450 3A4	Homo sapiens (human)	0.31
DNA gyrase subunit B	Staphylococcus aureus	4.32
DNA gyrase subunit A	Escherichia coli K-12	0.6845
DNA gyrase subunit B	Escherichia coli K-12	0.5632
DNA topoisomerase 4 subunit B	Staphylococcus aureus	6.485
DNA topoisomerase 4 subunit A	Staphylococcus aureus	4.8011
Gamma-aminobutyric acid receptor subunit beta-1	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit delta	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit gamma-2	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit alpha-5	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit alpha-3	Rattus norvegicus (Norway rat)	0.41
DNA gyrase subunit A	Staphylococcus aureus	4.32
Gamma-aminobutyric acid receptor subunit gamma-1	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit alpha-2	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit alpha-4	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit gamma-3	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit alpha-6	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit alpha-1	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit beta-3	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit beta-2	Rattus norvegicus (Norway rat)	0.41
DNA topoisomerase 4 subunit A	Bacillus subtilis subsp. subtilis str. 168	1.7
DNA topoisomerase 4 subunit B	Bacillus subtilis subsp. subtilis str. 168	1.7
GABA theta subunit	Rattus norvegicus (Norway rat)	0.41
Gamma-aminobutyric acid receptor subunit epsilon	Rattus norvegicus (Norway rat)	0.41

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	30 (81.08)	29.6817
2010's	6 (16.22)	24.3611
2020's	1 (2.70)	2.80

Authors

Authors	Studies
Bronstein, JC; Domagala, JM; Dunham, SA; Ellsworth, EL; Gage, JW; Gracheck, SJ; Hanna, DL; Huband, MD; Joannides, ET; Liu, JY; Nguyen, DQ; Sanchez, JP; Shapiro, MA; Showalter, HD; Singh, R; Stier, MA; Tran, TP; Watson, BM	1
Cohen, MA; Ellsworth, E; Gage, JW; Gibson, GW; Gracheck, SJ; Hanna, DL; Huband, MD; Skerlos, LA; Stier, MA; Sulavik, MC; Zurack, M	1
Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W	1
Ho, YR; Hung, KH; Janapatla, RP; Wu, CW; Wu, HM; Wu, JJ; Yan, JJ	1
Hirakata, Y; Imamura, Y; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Seki, M; Sugahara, K; Yamamoto, K; Yamamoto, Y; Yanagihara, K	1
Inagaki, H; Ito, M; Kawakami, K; Matsuhashi, N; Miyauchi, R; Ohki, H; Takahashi, H; Takemura, M	1
Inagaki, H; Kitamura, T; Komoriya, S; Kuroyanagi, J; Miyauchi, RN; Nagamochi, M; Odagiri, T; Sugimoto, Y; Takahashi, H	1
Inagaki, H; Kitamura, T; Komoriya, S; Nagamochi, M; Odagiri, T; Takahashi, H	1
Blaskovich, MAT; Pham, TDM; Ziora, ZM	1
Brady, SF; Koirala, B; Peek, J	1
Jones, RN; Pfaller, MA; Stilwell, M	1
Biedenbach, DJ; Jones, RN; Pfaller, MA	1
Andrews, JM; Boswell, FJ; Wise, R	1
Barrett, JF; Denbleyker, KL; Discotto, LF; Lawrence, LE	1
Biedenbach, DJ; Deshpande, L; Jones, RN	1
Appelbaum, PC; Davies, TA; Jacobs, MR; Nagai, K; Pankuch, GA	1
Barrett, JF; Frosco, M; Ho, H; Lawrence, LE; Mazzucco, CE; Ryan, BM; Warr, G	1
Appelbaum, PC; Bozdogan, B; Clark, CL; Davies, TA; Dewasse, B; Jacobs, MR; Nagai, K	1
Bello, A; Kappel, EM; Shakibaei, M; Stahlmann, R	1
Fukumoto, H; Furubo, S; Hayakawa, H; Kawamura, Y; Kizawa, K; Miyazaki, M; Morita, T; Nagai, A; Sanzen, T	1
Hooper, DC; Ince, D; Silver, LC; Zhang, X	1
Frisbee-Hume, S; Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H	1
Drlica, K; Eisner, W; Kreiswirth, B; Perl-Rosenthal, N; Zhao, X	1
Shakibaei, M; Stahlmann, R	1
Piddock, L; Ricci, V	1
Almaraz, F; Baquero, F; Cantón, R; Jones, RN; Loza, E; Martín, R; Morosini, MI; Pascual, A; Perea, E; Tubau, F	1
Baumann-Wilschke, I; Bello, A; Kastner, M; Rahm, U; Stahlmann, R	1
Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J	1
Biedenbach, DJ; Gordon, KA; Jones, RN	1
Barcia-Macay, M; Mingeot-Leclercq, MP; Seral, C; Tulkens, PM; Van Bambeke, F	1
Michot, JM; Mingeot-Leclercq, MP; Seral, C; Tulkens, PM; Van Bambeke, F	1
Blondeau, JM; Hansen, GT	1
Derkatch, S; Hoban, DJ; James, J; Laing, N; Noreddin, AM; Zhanel, GG	1
Fritsche, TR; Jones, RN; Sader, HS	1
Hsu, MC; Leunk, R; Makin, K; Roychoudhury, S; Twinem, T	1
Basugi, A; Eguchi, T; Hamada, Y; Kanai, I; Miyata, Y; Nasuno, T	1
Funaishi, K; Hattori, N; Katsutani, S; Kawamoto, K; Matsumoto, N; Matsumoto, Y; Ohashi, N; Taniwaki, M; Yamasaki, M	1

Reviews

1 review(s) available for garenoxacin and ciprofloxacin

Article	Year
Quinolone antibiotics. MedChemComm, 2019, Oct-01, Volume: 10, Issue:10 Topics:	2019

Other Studies

36 other study(ies) available for garenoxacin and ciprofloxacin

Article	Year
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms. Journal of medicinal chemistry, 2006, Nov-02, Volume: 49, Issue:22 Topics: Anti-Bacterial Agents; Bacteria; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Quinazolinones; Structure-Activity Relationship; Topoisomerase II Inhibitors	2006
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Pyrrolidines; Quinazolinones; Topoisomerase II Inhibitors	2007
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors	2007
Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: Bacterial Proteins; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Streptococcus agalactiae; Taiwan	2008
In vitro activity of garenoxacin against Streptococcus pneumoniae mutants with characterized resistance mechanisms. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Streptococcus pneumoniae	2009
Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria. Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19 Topics: Anti-Bacterial Agents; Drug Design; Drug Resistance, Multiple; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship	2009
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens. Journal of medicinal chemistry, 2013, Mar-14, Volume: 56, Issue:5 Topics: Animals; Anti-Bacterial Agents; Drug Design; Fluoroquinolones; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Quinolones; Rats; Respiratory Tract Infections; Spiro Compounds; Staphylococcus aureus; Streptococcus pneumoniae	2013
Design, Synthesis, and Biological Evaluation of Novel 7-[(3 aS,7 aS)-3 a-Aminohexahydropyrano[3,4- c]pyrrol-2(3 H)-yl]-8-methoxyquinolines with Potent Antibacterial Activity against Respiratory Pathogens. Journal of medicinal chemistry, 2018, 08-23, Volume: 61, Issue:16 Topics: Animals; Anti-Bacterial Agents; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; ERG1 Potassium Channel; Escherichia coli; Female; Humans; Macaca fascicularis; Male; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred CBA; Microbial Sensitivity Tests; Pneumococcal Infections; Quinolines; Respiratory Tract Infections; Streptococcus pneumoniae	2018
Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics. Bioorganic & medicinal chemistry letters, 2022, 02-01, Volume: 57 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; HEK293 Cells; Humans; Microbial Sensitivity Tests; Rifamycins; Staphylococcus aureus	2022
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci. Diagnostic microbiology and infectious disease, 2001, Volume: 39, Issue:2 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Indoles; Microbial Sensitivity Tests; Quinolones	2001
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States. Diagnostic microbiology and infectious disease, 2001, Volume: 39, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Europe; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Indoles; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; United States	2001
Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Moxifloxacin; Norfloxacin; Quinolines; Quinolones; Streptococcus pneumoniae	2001
Staphylococcus aureus mutants selected by BMS-284756. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:11 Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Indoles; Mutation; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus	2001
Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods. International journal of antimicrobial agents, 2001, Volume: 18, Issue:5 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Indoles; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Quinolones	2001
Antipneumococcal activity of BMS 284756 compared to those of six other agents. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1 Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Time Factors	2002
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:1 Topics: Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Indoles; Levofloxacin; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Sensitivity and Specificity; Staphylococcus aureus	2002
Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Biological Transport; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Indoles; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Streptococcus pneumoniae	2002
Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10 Topics: Administration, Oral; Animals; Anti-Infective Agents; Cartilage Diseases; Cartilage, Articular; Ciprofloxacin; Fluoroquinolones; Indoles; Knee Joint; Ofloxacin; Quinolones; Rats; Rats, Wistar	2002
Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs. The Journal of toxicological sciences, 2002, Volume: 27, Issue:3 Topics: Administration, Oral; Animals; Anti-Infective Agents; Cartilage, Articular; Ciprofloxacin; Dogs; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Indoles; Injections, Intravenous; Joint Diseases; Male; Norfloxacin; Quinolones; Toxicity Tests	2002
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:11 Topics: Alleles; Anti-Infective Agents; Ciprofloxacin; Cloning, Molecular; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression Regulation, Enzymologic; Indoles; Microbial Sensitivity Tests; Mutation; Plasmids; Quinolones; Staphylococcus aureus; Topoisomerase II Inhibitors	2002
Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients. Diagnostic microbiology and infectious disease, 2002, Volume: 44, Issue:2 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Indoles; Levofloxacin; Male; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Sensitivity and Specificity	2002
Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:3 Topics: Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Mutation; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus	2003
Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature rats. Archives of toxicology, 2003, Volume: 77, Issue:9 Topics: Achilles Tendon; Administration, Oral; Animals; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluoroquinolones; Male; Microscopy, Electron; Ofloxacin; Rats; Rats, Wistar	2003
Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:4 Topics: Aza Compounds; Bacteroides fragilis; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines	2003
[Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)]. Enfermedades infecciosas y microbiologia clinica, 2003, Volume: 21, Issue:8 Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus; Streptococcus pneumoniae	2003
Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats. Archives of toxicology, 2004, Volume: 78, Issue:2 Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Cartilage, Articular; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Male; Ofloxacin; Rats; Rats, Wistar; Specific Pathogen-Free Organisms	2004
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:1 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci	2004
Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; European Union; Fluoroquinolones; Microbial Sensitivity Tests; Reference Standards; United States	2004
Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:4 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line, Tumor; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Listeria monocytogenes; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Staphylococcus aureus; Time Factors	2005
Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Cell Line; Ciprofloxacin; Fluoroquinolones; Heat-Shock Response; Humans; Kinetics; Levofloxacin; Macrophages; Moxifloxacin; Ofloxacin; Quinolines; Quinolones	2005
Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Urinary Tract Infections	2005
Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:1 Topics: Anti-Bacterial Agents; Area Under Curve; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Models, Biological; Streptococcus pneumoniae; Time Factors	2006
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004). Diagnostic microbiology and infectious disease, 2007, Volume: 58, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Fluoroquinolones; Humans; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance	2007
In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone. Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:7 Topics: Anti-Bacterial Agents; Ciprofloxacin; Culture Media; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gene Expression; Microbial Sensitivity Tests; Mutation; Quinolones; Sequence Analysis, DNA; Streptococcus pneumoniae; Structure-Activity Relationship	2016
Malignant external otitis following radiotherapy for oral cancer: A case report. Medicine, 2018, Volume: 97, Issue:21 Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Asian People; Carcinoma, Squamous Cell; Ciprofloxacin; Ear Canal; Fluoroquinolones; Humans; Immunocompromised Host; Male; Mandibular Neoplasms; Mouth Neoplasms; Oral Fistula; Otitis Externa; Pseudomonas aeruginosa; Temporal Bone; Therapeutic Irrigation; Tomography Scanners, X-Ray Computed; Treatment Outcome	2018
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report. Annals of hematology, 2019, Volume: 98, Issue:8 Topics: Aged; Anti-Bacterial Agents; Antibody Specificity; Antifungal Agents; Autoantibodies; Autoimmune Diseases; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Substitution; Drug Therapy, Combination; Factor V; Factor V Deficiency; Fluoroquinolones; Humans; Levofloxacin; Male; Meropenem; Micafungin; Partial Thromboplastin Time; Pneumonia; Prothrombin Time	2019